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Palavras-chave 
Resumo 
As infecções por C. parapsilosis têm vindo a aumentar nos últimos 20 anos. 
As suas características intrínsecas de adesão e capacidade de formação de 
biofilmes são um factor critíco de infecção, sendo os pacientes transplantados 
ou com o sistema imunitário comprometido ou mesmo os neonatos de baixo 
peso o grupo de risco mais afectado. Os prestadores de cuidados de saúde são 
o meio de transmissão mais comum para a infecção por esta levedura.  A 
classe dos antifúngicos azóis são a primeira linha de defesa para tratamento 
de infecções por este tipo de leveduras. Estes actuam inibindo a enzima 
lanosterol 14α-demethylase, enzima constituinte da via biossintética do 
ergosterol. Um estudo recente demonstrontrou que a resistência aos azoles 
em C. parapsilosis poderá ter os mesmos mecanismos observados e 
estudados em C. albicans. Uma estirpe resistente obtida após exposição a 
Posaconazole revelou uma sobre-expressão de 13 genes envolvidos na 
biossíntese do ergosterol, entre eles dois factores de transcrição, Upc2 e 
Ndt80. Com vista a avaliar o papel destes factores de transcrição na 
resistência aos azoles em C. parapsilosis, pretendeu-se efectuar a delecção 
dos dois genes usando a ferramenta molecular SAT1-flipper cassette. Apenas 
um alelo do gene NDT80 foi deletado, originando um fenótipo distinto em 
comparação com a estirpe original BC014, em particular na sua capacidade 
de adesão e de formação de biofilmes. Foram realizados testes de 
susceptibilidade embora sem qualquer diferença evidente entre fenótipos. 
Estes resultados demonstram que o gene NDT80 pode ser um regulador 
negativo da capacidade de adesão de C. parapsilosis, afectando também o seu 
potencial de formação de biofilmes.   
Candida parapsilosis, Factores de transcrição, NDT80, UPC2, adesão e 
biofilme 
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Abstract                                  
C. parapsilosis infections incidence has been increasing for the past 20 years. 
Its caracteristics of adhering and forming biofilms are a critical factor for 
infection caused by this organism, affecting from immunocompromised or 
transplanted patients to low-birth-weight neonates. The health-care workers 
are a major transmission vehicle of this fungus. The azoles class of antifungal 
drugs are the first and most common line of defense to treat infections by this 
type of yeast species. Its mode of action on the yeast cell works by inhibiting 
the lanoststerol 14α-demethylase, an enzyme belonging to the ergosterol 
biosyntethic pathway.. On a recent study it has become clear that C. 
parapsilosis antifungal azole resistance may display similar resistance 
mechanisms that the ones described for C. albicans. A resistant strain 
obtained after exposure to posaconazole has shown an upregulation of two 
transcriptional factors, Upc2 and Ndt80. The aim of this work was to assess 
the role of these two transcriptional factors on C. parapsilosis azole 
resistance. For that, it was intended to knockout both genes using the SAT1-
flipper cassette. The strain obtained after disruption of one copy of NDT80 
gene displayed an unexpected phenotype, concerning adhesion and biofilm 
formation, comparatively to the wild-type BC014 strain. It were also made 
susceptibility tests although with no evident changes. These results 
demonstrate that NDT80 gene may be a negative regulator of C. parapsilosis 
adherence to abiotic and biotic substrates, impairing also biofilm formation. 
Candida parapsilosis, transcription factors, NDT80, UPC2, adhesion, 
biofilm 
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(MAL2p) and the ACT1 promoter represented by the bent arrows, and the transcription 
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Figure 5. Confirmation of the pNG4 excision from C. parapsilosis BC014. Clones were grown 
in YPD agar plate (A) and YPD agar plate supplemented with Nourseothricin 200µg ml-1 (B). 
Cp1, Cp2, Cp3 clones were susceptible to nourseothricin. 
Figure 6. Confirmation of the disruption of one copy of the NDT80 gene (NDT80/ndt80). An 
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Figure 8. NDT80 aneuploidy increases C. parapsilosis adhesion ability. Yeast adhesion ability to 
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Figure 12 – C. parapsilosis morphological changes triggered by the deletion of one copy of 
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VI. Introduction 
Candida parapsilosis – History and characteristics 
C. parapsilosis phylogenetic classification has had undergoing several alterations 
concerning its pathogenic potential. First discovered by Ashford in 1928, it was isolated 
from stool of a patient in Costa Rica and named as Monilla parapsilosis since it was 
incapable of fermenting maltose7. Described as a non-pathogenic yeast, only in 1940 after 
being considered the agent responsible for the death of a drug user with endocarditis, it 
was included in the genus Candida and named C. parapsilosis8. In 2005, this species was 
subdivided in 3 closely related species, morphologically and genetically; C. parapsilosis 
(sensu stricto), C. orthopsilosis and C. metapsilosis59, being C. parapsilosis (sensu 
stricto) the responsible for the vast majority of clinical infections9, in comparison with 
the latter two. 
Many of the major human fungal pathogens are known to undergo morphological 
changes, which in certain cases are associated with virulence. C. parapsilosis colonies 
display diversified shapes; oval, round and cilindric, having in common the white milky 
colour. They do not form true hyphae and only exist in two morphogenic forms: yeast or 
pseudohyphae, in contrast with other Candida species, like C. albicans36.  In the last 
twenty years, it is known that infection by this pathogen has increased. So, it is of the 
most importance to describe the epidemiology, virulence traits, clinical manifestations, 
genetics, and antimicrobial susceptibility of C. parapsilosis to provide a broad and up-to-
date reference for this pathogen10. 
 
Prevalence 
Invasive yeast and mould infections in immunocompromised patients have consistently 
shown a lower incidence in comparison with bacterial infections, in particular on the 
hospital environment1.  
Infections by these pathogens are increasing and have been associated with a significant 
increase in the number of individuals receiving immunosuppressive therapies, such as 
cancer patients on chemotherapy and organ transplant recipients37,38. 
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In 2003, a surveillance program was conducted in Europe, in particular on Nordic 
countries, in order to study the prevalence of Candida spp. in the period of time of two 
years (2004-2006)2. The incidence of these species was more than 50% of total hospital 
infections, being Candida albicans the most common cause of infection. 
As one of the most virulent Candida species, infections by Candida parapsilosis have 
became more prevalent in the last twenty years, being therefore actually considered an 
emergent fungal pathogen. In some cases it is the most common species on fungal 
bloodstream infections (BSI) in the nosocomial environment60, even surpassing C. 
albicans3,4, frequently associated with disease and even death, in particular in infants and 
immunocompromised patients. Nevertheless, C. parapsilosis can subsist in the human 
organism being a commensal pathogen, particularly in the human skin, with limited 
pathogencity by intact integument. 
The increment of invasive candidiasis infections is due to instrinsic organism factors. This 
increasing trend of C. parapsilosis has been attributed to several factors including the 
organism’s growth capacity, its affinity for intravascular devices and prosthetic materials, 
gastrointestinal colonization and transmission from the colonized hands of healthcare 
workers10,44,46. The affinity of C. parapsilosis for foreign material is shown by infections 
related to peritoneal dialysis catheters and prostheticheart valves, and this characteristic 
may be important in infections of cancer patients with indwelling access devices52,54, as 
well on neonatal intensive care units56,57. 
 
Antifungal therapy 
In order to treat cases of candidiasis, several antifungal agents have been used through 
the past until nowadays. The development of new therapeutic forms of treatment has been 
enhanced on the last few years, in particular on a molecular level, but they are not yet an 
effective and somewhat limited alternative to classic antifungal treatment.  
There are at least 5 classes of antifungals that are most common on the clinical 
environment to treat Candida spp. infections, including polyenes, echinocandins, 
nucleoside analogs , and azoles49. 
Within these classes, the azoles are the most commonly used on medical practice due to 
their broad spectrum and effectiveness. This specific class has been in constant evolution, 
having the first azole marketed  (ketoconazole) on 1958, and since then, numerous other 
azoles have been available commercially, the latter one on 2005 (posaconazole). 
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The azole class of antifungals work by inhibiting the lanosterol 14α-demethylase, an 
enzyme that belongs to cytochrome P450. This enzyme has a key role in the ergosterol 
synthesis, and is encoded by the ERG11 gene18 (Figure 1) 
 
 
 
 
Up to this date, little is known about the molecular mechanisms underlying the C. 
parapsilosis pathogenicity, acting C. albicans as a “comparison species” due its extensive 
knowledge regarding its molecular and genomic caracteristics.  
  
Molecular mechanisms of azole resistance 
Yeasts are, like the most part of microorganisms, adaptable to specific types of conditions 
of stress, whether they are pH, temperature, saline and even oxidation related. It can alter 
their genome to better withstand these conditions, and in the process develop mechanisms 
of resistance to antifungal drugs, namely azoles11. In recent years, intense research has 
been conducted, leading to a better understanding of the molecular mechanisms of azole 
resistance, among which the most prevalent in C. albicans are: (i) reducing intracellular 
Figure 1 Azole antifungal action mechanism – The azole drug enters the fungal cell and  inhibites the 14α-demethylation of 
lanosterol, leading to the accumulation of methylated sterols on the interior of the cell, ultimately causing cell death. 
(http://www.biochemsoctrans.org/bst/033/1210/bst0331210f01.htm?resolution=HIGH) 
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concentration of the azole drugs by overexpression of efflux pumps belonging to either 
the ATP-binding cassette superfamily (CDR1, CDR2) or the major facilitator superfamily 
(MDR1); (ii) up-regulation of the ERG11 gene encoding 14α-lanosterol demethylase, the 
primary target of azole drugs; and (iii) point mutations in ERG11 causing amino acid 
changes that lead to decreased affinity for azole drugs19. These mechanisms can combine 
and even have a synergistic effect on a single isolate20.  
The hemoprotein ERG11p is the azole target in Candida spp.. It has the function of fixing 
oxygen atoms, needed to the enzymatic reactions24. This protein is involved in the 
ergosterol biosynthetic pathway of the fungi by demethylating lanosterol and catalyzing 
the first step in ergosterol synthesis27. With azole exposure, the ergosterol pathway is 
inhibited, and methylated sterols such as 14α-metil-3,6-diol have increased intracellular 
accumulation, consequently inhibiting the cellular growth. 
Alterations on the ergosterol biosynthetic pathway can induce azole resistance. On C. 
albicans the decrease of intracellular drug accumulation may be caused by 
overexpression of the efflux pump genes, and mutations in ERG11 gene. They are 
described as being among the most common mechanisms of azole resistance28. 
The exposure of C. albicans to azoles is also known to result in accumulation of 14-
methylfecosterol, which is subsequently converted by the sterol 5,6-desaturase to 14-
methyl-ergosta-8,24 (28)dien-6-diol (14-methyl-3,6-diol). Since 14-methylfecosterol is 
capable of supporting fungal growth and 14-methyl-3,6-diol is toxic to the cell, 
inactivation of the sterol 5,6-desaturase renders the cells resistant to azoles.This is 
described as a third possible mechanism of resistance in Candida spp.25. 
Azoles are a fungistatic drug class, this is an important factor to consider in resistant 
strains, providing a selective pressure to the organism to become resistant, developing 
mechanisms in which the gain-of-function mutation rate is significantly higher. Thus a 
significant and increased number of azole-resistant strains can be yielded29.  
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Regulation of transcription factors (TF) 
Up to date, the transcriptional factors of the zinc cluster family have been identified as 
regulators of the transcriptional control of azole resistance in C. albicans. They mediate 
the upregulation of the ergosterol biosynthesis genes, acquiring called “gain-of-function” 
mutations. Azoles exposure trigger mutations, either in transcription factors or in the 
azole target gene. Once acquired, transcription factors (TF) become hyperactive, 
increasing the expression of its regulated-target genes, such as  ERG11 gene and the 
multidrug efflux pumps of the ABC transporter and other major facilitator 
superfamilies13.  
In C. albicans, Upc2p has been described as a TF that targets genes of the ergosterol 
biosynthesis pathway and it is correlated as an important factor of regulation of the 
ERG11 gene. Mcpherson et al.22 identified UPC2 as an homologue of ECM22, an 
important gene involved in the ergosterol biosynthesis in Saccharomyces cerevisae. 
Furthermore, they have found that the deletion of UPC2 gene has lead to impaired growth 
under anaerobic conditions and high susceptibility to azoles. Conversely, an 
overexpression of Upc2p cause an increased resistance to these drugs.  
Furthermore, Dunkel et al.31 showed that azole resistance is linked to a gain-of function 
mutation in the sterol metabolism regulator Upc2p, leading to constitutive expression of 
ergosterol biosynthesis genes. 
The Ndt80p TF in C. albicans controls positively the expression of the gene encoding 
drug efflux pump CDR130. It has been described that Ndt80p is required for the hyphal 
growth in response to different filament-inducing cues and for the proper expression of 
the filamentous transcriptional genes program which characterize this type of growth, 
such as the chitinase Cht3p and the cell wall glucosidase Sun41p33. Moreover, Ndt80p 
was found on the promoters of ergosterol biosynthesis genes, including on the azole target 
ERG11p. 
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Case of study 
Despite improvement of antifungal therapies over the last 30 years, antifungal resistance 
is a major concern on the clinical practice34.  
On Silva et al.35, it becomes clear that C. parapsilosis antifungal azole resistance may 
have the same resistance mechanisms that are underlying C. albicans resistance, in 
particular the activation of efflux pumps by the upregulation of MDR1 gene. 
On this study, an azole-susceptible strain (BC014) was in vitro exposed, for a maximum 
of 60 days, to a constant concentration of three different azoles: fluconazole, voriconazole 
and posaconazole, separately. A set of resistant strains was generated.  
The resistant strain obtained after exposure to posaconazole has shown an upregulation 
of 13 genes involved in ergosterol biosynthesis, and two transcriptional factors, UPC2 
and NDT80. The two upregulated TF are well documented and identified in C. albicans, 
and are correlated with the overexpression of ERG genes. The results of this study were 
the basis for this experimental work, to better understand the roles of these two TF in C. 
parapsilosis. 
 
VII.Objectives 
This experimental has the main goal to assess the role of both NDT80 and UPC2 genes 
in azole resistance in C. parapsilosis. 
 
 
 
VIII.Materials and Methods 
 
Growth conditions 
Escherichia coli – DH5α 
Competent cells of E.coli DH5α were used for plasmid construction and cloning. They 
were grown in liquid or solid (containing 2% agar) Luria-Bertoli (LB) medium. Positive 
clones were grown in the same medium supplemented with chloranphenicol (Clo) to a 
final concentration of 25 µg ml-1 and were later stored at -80ºC in LB containing 20% 
glycerol. 
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C. parapsilosis - BC014 
C. parapsilosis BC014 strain was grown in liquid YPD (Yeast Peptone Dextrose) medium 
(1% yeast extract, 2% peptone, 2% dextrose) or in YPD solid (containing 2% agar). For 
transformants selection YPD medium was supplemented with Nourseotricin to a final 
concentration of 200 μg ml-1 (Nou 200).  
All C.parapsilosis transformants were later stored in YPD medium with 40% glycerol, at 
-80ºC.  
 
E. coli competent cells preparation 
E. coli DH5α was incubated at 37ºC overnight and inoculated in 5 ml of liquid LB 
medium until reaching an optic density (OD550nm) of 0.3. Then, 4 ml of the culture was 
inoculated in 100 mL of LB medium and E. coli was grown under the same conditions 
until reaching a similar OD550nm. Afterwards, it was put on ice for 5 minutes and 
centrifuged at 1,700 g for 5 minutes at a temperature of 4ºC. The pellet was then 
ressuspended in 40 ml of ice-cold TFBI solution (30mM KOAc, 50mM MnCl2, 100 mM 
RbCl2, 10 mM CaCl2, 15% glicerol) and again centrifuged at 665 g for 5 minutes at 4ºC. 
Finally, pellet was ressuspended in 5 ml of ice cold TFBII solution (10mM NaMOPS  pH 
7.0, 75mM CaCl2, 10mM RbCl2, 15% glicerol ), incubated on ice for 5 minutes and gently 
divided in 200 µl aliquots in Eppendorf tubes and stored at -80ºC until use. 
 
Plasmid Construction 
The pCD8 plasmid, gently gifted by Prof. Geraldine Butler, contains the SAT1 gene 
which confers resistance to nourseotricin (Nou). This plasmid was used to develop the 
NDT80 and UPC2 disruption cassetes as described by Ding et al.14. Upstream and 
downstream sequences of both genes were amplified by PCR as described in Table 1, 
using as template the using C. parapsilosis BC014 genomic DNA. 
Upstream sequence of the NDT80 gene was amplified through the following PCR 
program: 95ºC for 2 minutes for denaturation, followed by 30 cycles of 95ºC, 51ºC, 72ºC 
for 30 seconds each, with the final extension step of 72ºC for 10 minutes. For the 
downstream sequence the PCR program comprised a 95ºC denaturation step for 2 minutes 
, followed by 30 cycles of 95ºC, 63ºC, 72ºC for 30 seconds each, with the final extension 
step of 72ºC for 10 minutes. 
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The UPC2 fragments cloned into the pCD8 plasmid were amplified by PCR with the 
primers UPC2_up_F and UPC2_up_R; UPC2_down_F and  UPC2_down_R,  . 
To amplify the upstream region of the UPC2 gene (491 bp) , the temperature profile used 
was: 95ºC for 2 minutes for denaturation, followed by 30 cycles of 95ºC, 65ºC, 72ºC for 
30 seconds each, with the final extension step of 72ºC for 10 minutes. For the downstream 
fragment (463 bp), PCR program comprised a 95ºC denaturation step for 2 minutes, 
followed by 30 cycles of 95ºC, 57ºC, 72ºC for 30s each, with the final extension step of 
72ºC for 10 minutes (Table 1).  
 
Table 1: Components and concentrations used in PCR to amplify both upstream and downstream regions of the NDT80 and UPC2 
genes 
Reagents Final Concentration Final Volume 
Taq Buffer 10x  1x 2,5µl 
dNTP 0,2 mM 0,5µl 
Primer_F (up/down) 4 pmol 1µl 
Primer_R (up/down) 4 pmol 1µl 
H2O Adjusted to 25 µl  
Taq DNA Polymerase  1 U 0,2µl 
Genomic DNA   About 100 ng  
 
Both upstream and downstream sequences of the NDT80 and UPC2 genes were amplified 
by PCR using primers designed in the OligoExplorer program and listed on Table 2. PCR 
reactions were carried out in a BioRad MyCycler Personal Thermal Cycler® and its 
products were confirmed for its correct size by electrophoresis in 0,8% agarose gel. 
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Table 2. Primers used to amplify the upstream and downstream sequences of the C. parapsilosis NDT80 and UPC2 genes 
 
 
 
Finally, fragments were digested with KpnI and ApaI, in the case of upstream fragments, 
and SacII/SacI, in the case of downstream fragments. These fragments were ligated 
sequentially to the digested plasmid.  
 
Plasmid DNA E.coli extraction 
Plasmids used were extracted from E. coli DH5α according to NZY Miniprep Kit protocol 
(NZYtech®). 
 
DNA agarose gel electrophoresis 
DNA electrophoresis was performed using a constant voltage of 80 V (Power Pac Basic, 
Bio-Rad®) for 60 min, running in TAE buffer 1x (0.04 M Tris, 50 mM EDTA pH 8, 1 M 
glacial acetic acid), in a 0,8% agarose gel (Ultra Pure Grade NZYtech®) incorporating 
ethidium bromide (0,5 µg/mL). DNA samples were loaded on agarose gel mixed with 1x 
loading buffer (10 mM Tris-HCl (pH 7.6); 0,03% bromophenol blue; 60% glycerol; 60 
mM EDTA). DNA was visualized and analyzed in a GelDocXR equipped with Imaging 
System from BioRad®. 
 
 
 
 Primer                                                                      Sequence (5’-3’) 
NDT80_up_F GGG GGT ACC GGC AAT TTT GAT TTT TGG GTT C 
NDT80_up_R GGG GGG CCC GAG GCA CCA CCA GCA GTA GAG T 
NDT80_down_F TCC CCG CGG GAT GGG AGA AAA AAC TGA ACC 
TTG 
NDT80_down_R CGA GCT CAG ATG GCA TTG TAG TCA GTA GCA TC 
UPC2_up_F GGGGGTACCTCTCGTGTCTTGATTTTTTGTGTAG 
UPC2_up_R GGGGGGCCCGCTTGTTCTCCTTGCGTGTGTATTA 
UPC2_down_F AAAAAGCGGCCGCATGGATGGGAAATGGATACATG 
UPC2_down_R gggGAGCTCTTCGTTGATGATAGAAAAGTTAGGA 
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Plasmid DNA restriction 
For fragment cloning, approximately 3 µg of plasmid DNA were used with about 3 Units 
(U) of each restriction enzyme (KpnI/ApaI and SacII/SacI). Reactions with Fast Digest 
enzymes (KpnI/ApaI) were incubated at 37ºC for a maximum of 20 minutes, whilst 
reactions with conventional restriction enzymes (SacII/SacI) were incubated for a period 
of 16 hours at 37ºC. The linearized plasmid product was then purified using QIAquick 
Nucleotide Removal Kit (Qiagen) according to the manufacturer protocol. 
 
 
Plasmid DNA Desphosphorilation 
About 1 µg of the digested purified plasmid was desphosphorilated by 1U of alkaline 
phosphatase (AP) in a reaction of 30 µl containing AP buffer 1x (0.5 M Tris-HCl, 50 mM 
MgCl2, pH 8.5, at 37ºC for 30 minutes and 2 hours. AP inactivation occurred at 65ºC for 
10 minutes. 
 
DNA Ligation 
DNA fragment ligation to a restricted desphophorylated plasmid was carried out by T4 
DNA Ligase enzyme (Fermentas). Ligation reation included approximately 30-60 pmol 
of the plasmid, 90-180 pmol of DNA fragment, T4 DNA Ligase buffer 1x (250 mM Tris-
HCl pH 7.6, 50 mM MgCl2, 5 mM ATP, 5 mM DTT, 25% polietilene glicol 8000), 1 U 
of T4 DNA Ligase and H2O MilliQ. Inactivation of T4 DNA Ligase occurred at 65ºC for 
10 minutes. 
 
E.coli Transformation 
For DNA cloning, competent E.coli DH5α cells were transformed with ligation reaction. 
For that, 200 µl of DH5α cells were mixed with 5 µl of the ligation reaction and incubated 
for a period not exceeding 30 minutes. A negative control, without DNA was performed. 
Posteriorly, a heat shock treatment at 42ºC for 90 seconds was given to the mixture, 
followed by incubation on ice for 2 minutes. Then it was added 800µl of SOC medium 
(2% tryptone, 0.5% yeast extract, 10 mM NaCl, 2.5 mM KCl, 2.0 mM glucose) and 
incubated for 1 hour at 35ºC to allow cells to recover. Following a centrifugation for 1 
minute at 660 g at room temperature, about 50µl of the cell mixture was plated onto LB 
agar medium supplemented with Clo 25 mg ml-1. Plates were incubated overnight at 37ºC. 
 23 
 
The grown colonies of DH5α containing plasmid of interest were inoculated and grown 
overnight for 37ºC in 5 ml of LB medium supplemented with 25 mg ml-1  Clo for plasmid 
DNA extraction.   
 
E. coli DH5α clone plasmid DNA extraction 
From the cell suspension resulting of the described above, about 4 ml of the culture were 
centrifuged at 18,000 g at room temperature for 5 minutes. The pellet was washed with 1 
ml of Solution I (50 mM glucose, 25 mM Tris pH 8.0, 10 mM EDTA pH 8.0) and 
vortexed, followed by a centrifugation at room temperature at 18,000 g for 5 minutes. 
The supernatant was removed and the pellet ressuspended in 100 µl of the Solution I, then 
200 µl of solution II (0.2 M NaOH, 1% SDS ) and 150 µl of ice-cold Solution III (3M 
Potassium acetate pH 5.0) were added and mixed by inversion. Following an incubation 
on ice for 5 minutes, the mixture was then centrifuged at 4ºC for 10 minutes and the 
supernatant transferred to a new microtube. To the supernatant it was added 0.7 vol. of 
isopropanol and left to incubate for 10 minutes, followed by a centrifugation at 18,000 g 
at 10ºC for 10 minutes. The resulting pellet was then washed with ethanol 70% and again 
centrifuged at 18,000 g for 10 minutes at 4ºC. The aqueous phase was removed and the 
pellet dried for 30 minutes at 37ºC and ressuspended in sterile H2O with 10 mg ml
-1 
RNAse A (NZYtech®). 
 
 
Clone Screening 
Plasmid DNA extracted was used as template in a PCR to screen for positive clones. 
Specific primers were used (Table 2) to confirm the presence of  upstream and 
downstream sequences of UPC2 and NDT80 genes in the construction of the disruption 
cassettes. Nucleotide sequence of the cloned fragments were confirmed by sequencing. 
Thus, two disruption cassette for UPC2 and NDT80 genes were obtained, pNG3 and 
pNG4, respectively. 
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Amplification of the disruption cassette 
Disruption cassettes in plasmids pNG3 and pNG4 were amplified by PCR using the pairs 
of primers UPC2_up_F/UPC2_down_R and NDT80_up_F/NDT80_down_R, 
respectively. PCR reactions were prepared as described in Table 3 and PCR program was 
carried out in a BioRad MyCycler Personal Thermal Cycler® as described above. PCR 
products were visualized after DNA electrophoresis in 0,8% agarose gel and  purified 
using QIAquick PCR purification Kit (QIAGEN). The PCR amplification temperature 
profile for both plasmids comprised a 95ºC denaturation step for 5 minutes , followed by 
30 cycles of 98ºC, followed by an extension step at 65ºC for 2:20 minutes for pNG3 and 
2:30 for pNG4, with the final extension step of 72ºC for 5 minutes. 
 
Table 3. PCR reaction mix prepared to amplify disruption cassette in pNG3 and pNG4 plasmids. 
Reagents Stock Volume Final Concentration 
 H2O  milliQ Adjusted to 25 µl  
    Primer F (10 µM)  0,75 µl 0.3 µM 
    Primer R (10 µM)  0,75µl 0.3 µM 
    DNA  1µl 100 ng µl-1 
    KAPA HiFi Hot Start ReadyMix   0,2 µl 1x 
 
  
 
C. parapsilosis Transformation by electroporation 
C. parapsilosis transformation protocol was adapted from Zemanova et al.16 with minor 
adjustments. A BC014 C. parapsilosis colony was inoculated overnight in 85 ml YPD 
medium at 30ºC until reaching an OD600 of approximately 1.8-2.0. Cells were collected 
by centrifugation at 5000 g for 5 minutes. Then, the pellet was suspended in 10 ml of 
Tris-EDTA buffer (10 mM Tris-HCl pH 8, 1 mM EDTA) containing 10 mM of ditiotreitol 
(DTT). After, yeast suspension incubation at 30ºC for 1 hour, with agitation (100 rpm), it 
was added 40 mL of ice-cold distilled water, and transferred to a clean cold 50 mL falcon 
which was centrifuged for 5 minutes at 5,000 g. Supernatant was discarded and pellet was 
washed twice , first with 50 ml of cold destilled water and then with 10 ml of ice-cold 1 
M sorbitol. After removing the supernatant, competent cells were ressuspended in 125 μl 
of 1 M sorbitol, divided in aliquots of 50 μl, mixed with approximately 1 μg of disruption 
cassette and incubated for 5 minutes on ice. A negative control without DNA was made. 
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Mixture was transferred into a 1mm electroporation cuvette and transformed at 1,25 kV 
for 5 ms in a Gene Pulser X-cell (Bio-Rad) electroporator. After electroporation, cells 
were imediatelly suspended in 950µl of YPD medium containing 1 M Sorbitol and 
allowed to recover for 4 hours at 30ºC with agitation (180 rpm). Finally, 100 µl of the 
mixture were washed and plated onto YPD agar medium supplemented with Nou 200 µg 
ml-1. Transformants were obtained after 48-72 hours of incubation at 30ºC. 
 
SAT1-Flipper cassette genome integration - screening and recycling 
In order to confirm disruption cassete integration in the target gene locus, clones grown 
in Nou were screened by PCR. Primers used were designed to amplify genomic DNA 
region adjacent to the location of the gene (CpNDT80gen_F or CpUPC2gen_F) (Table 
5), and the FLP recombinase region located within the SAT1-Flipper cassete (FLP_R).   
Reactions were prepared as described in Table 2 and the following PCR program: 95ºC 
for 3 minutes; 30 cycles of 95ºC for 30 seconds, 66ºC for 30 seconds and 72ºC for 3 
minutes, ending with an extension step at 72ºC for 10 minutes, was used. PCR reactions 
were carried out in a BioRad MyCycler Personal Thermal Cycler®. Products reactions 
were runned in a electrophoresis in 0,8% agarose gel.  
 
Table 5. – Primers used for screening disruption cassette integration at its target genomic locus.  CpNDT80gen_F and CpUPC2gen_F 
comprise the region adjacent to the location of  NDT80 and UPC2 genes, respectively. FLP_R  belongs to the FLP recombinase region 
located within the SAT1-flipper cassette. 
Primer Sequence (5´-3´) 
CpNDT80gen_F GCCTTTTACATCTATCGAAGTCAAACTTG 
CpUPC2gen_F CGCTATTCGTTTATTGTGTAGTCAAGC 
FLP_R AAG GAA AAA AGC GGC CGC TTT ATG 
ATG GAA TGA ATG GGA TG 
 
 
In order to excise the SAT1 flipper cassete, transformants were grown in YPM (Yeast 
Peptone Maltose) medium (yeast extract 1%, peptone 2%, maltose 2%), at 30ºC, 180 rpm, 
overnight. From this, approximately 1x102 recycled cells were plated onto YPD agar 
medium supplemented with Nou 20 μg ml-1. Smaller colonies were chosen to screen for 
sucessfull cassette recycling. 
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Genomic DNA extraction  
Genomic DNA extraction of C. parapsilosis transformants was carried out as described 
by Hoffman and Winston17 , with certain modifications. 
Approximately 1,5 ml of yeast culture grown in YPD medium at 30ºC overnight with 
agitation (180rpm) were transferred to a microtube and centrifuged at 20,000 g for 5 
minutes. The supernatant was discarded and pellet was suspended in 200µl of lysis buffer 
(2% Triton X-100, 1% SDS, 100 mM NaCl, 10 mM Tris-HCl pH 8.0, 1 mM EDTA pH 
8.0) and briefly vortexed. Yeast suspension was then frozen at -80ºC for 5 minutes and 
immediately transferred to a 95ºC bath for 1 minute. This process was repeated at least 
two times and vortexed for 30 seconds. After adding 200 µl of chloroform, the mixture 
was then vortexed for 2 minutes with glass beads and centrifuged at 20,000 g for 3 
minutes. The aqueous phase was then collected to a new microtube containing 400 µl of 
ice-cold absolute ethanol, mixed by inversion and incubated for 1 hour at -80ºC. The 
microtube was then centrifuged at 20,000 g for 5 minutes, and the pellet washed with 0,5 
ml of 70% ethanol. Following another centrifugation, DNA was dried at 37ºC in order to 
remove any ethanol trace. Finally, DNA was resuspended in 50 µl in TE (10 mM Tris-
HCl (pH 8), 1 mM EDTA) with 1 µl of RNAse 10 mg µl-1 and incubated for 1 hour at 
37ºC. The quality and concentration was measured by espectophotometry (Nanodrop) 
and run in 0,8% agarose gel electrophoresis. 
 
Confirmation of excision of the SAT1-Flipper cassette 
Cassete excision was confirmed by PCR using the following pair of primers 
NDT80gen_up_F/NDT80_down_R and UPC2gen_up_F /UPC2down_R, respectively, 
for NDT80 and UPC2 genes. Genomic DNA from the clones grown in YPM was used as 
template. PCR reactions were prepared as described in table 6. Temperature profile of 
the PCR programmme comprised a denaturation step at 95ºC for 2 minutes, followed by 
30 cycles of 95ºC for 30 seconds, 66ºC for 30 seconds and 72ºC for 3 minutes and a final 
extension step of 72ºC for 10 minutes, to screen for NDT80 gene. For UPC2 gene, PCR 
program used was similar with a minor difference, Tm was adjusted to 65ºC. PCR 
reactions were carried out in a BioRad MyCycler Personal Thermal Cycler®. PCR 
products were visualized after electrophoresis in 0,8% agarose gel. 
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Table 6. PCR reaction mix prepared  for excision  confirmation of the SAT1-Flipper cassette 
Reagents Stock Volume Final Concentration 
 H2O  milliQ Adjusted to 25 µl  
 Buffer (10x) 2,5 µl 1x 
 dNTPs (10 mM) 0,5 µl 0.2 mM 
    Primer gen_F (100 pmol µl-1)  1 µl 4 pmol 
    Primer R (100 pmol µl-1)  1µl 4 pmol 
    DNA  1µl 100 ng µl-1 
    Taq DNA polymerase (5U µl-1)  0,2µl 1U 
 
 
SADH gene amplification/restriction 
In order to confirm that clones obtained belong to the C. parapsilosis sensu stricto, 
amplification of the SADH gene was carried out, as described in Tavanti et al.26. Genomic 
DNA, used as template, together with the primers SADH_F and SADH_R (Table 7) and 
other components listed in Table 8 were part of the PCR reaction. Temperature profile 
comprised a denaturation step at 95ºC for 2 minutes, followed by 30 cycles of 95ºC for 
30 seconds, 50ºC for 30 seconds and 72ºC for 30 seconds. The final extension step 
occurred at 72ºC for 10 minutes. PCR amplification reaction was carried out in a BioRad 
MyCycler Personal Thermal Cycler®. PCR product (716 bp) was visualized by 
electrophoresis in a 0,8% agarose gel. Then, was digested with 10 U of FastDigest® BanI 
enzyme (Fermentas®) in a 30 µl reaction for 5 minutes. Digested products were then run 
on a 0,8% agarose gel. 
 
Table 7: Primers used for C. parapsilosis SADH gene PCR amplification. 
Primer Sequence (5´-3´) 
SADH_F GTTGATGCTGTTGGATTGT 
SADH_R CAATGCCAAATCTCCCAA 
.  
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Table 8. PCR reaction mix prepared for C. parapsilosis SADH gene amplification 
Reagents Stock Volume Final Concentration 
 H2O  milliQ Adjusted to 25 µl  
 Buffer (10x) 2,5 µl 1x 
 dNTPs (10 mM) 0,5 µl 0.2 mM 
    Primer F (100 pmol µl-1)  1 µl 4 pmol 
    Primer R (100 pmol µl-1)  1µl 4 pmol 
    DNA  1µl 100 ng µl-1 
    Taq DNA polymerase (5U µl-1)  0,2µl 1U 
. 
 
 
Biofilm protocol assay 
Biofilms were formed on commercially available presterilized, polystyrene, flat-bottom 
12-well flat bottom plates. At first, 10 ml of cell suspension grown in Sabouraud Dextrose 
Broth medium was centrifuged at 5000 g and washed twice with sterile H2O. Pellet was 
diluted in RPMI-1640 (Sigma-Aldrich®) medium to a concentration of approximately 1 
x 106 cells/ml. From yeast suspension prepared, 1 ml was put into each well and incubated 
for 24 h, 48 h and 72 h at 35ºC. RPMI-1640 medium was used as a negative control.  
Two different in vitro parameters were assessed to quantify biofilm formation, Crystal 
Violet (CV) and XTT (2,3-Bis-(2-Methoxyl-4-Nitro-5-Sulfophenyl)-2H-Tetrazolium-5-
Carboxanilide) assays.  
The protocol used for CV staining was adapted from O´Toole et al.71. In the first biofilm 
biomass quantification is carried out by adding 1 ml of 99% methanol to each well 
followed by an incubation for 15 minutes. Methanol is then removed and air-dried for 30 
minutes. To stain the formed biofilm 0,02% of CV was added for 20 minutes, being after 
removed and washed twice with sterile H2O. Water traces were then removed and biofilm 
was suspended in 1,5 ml of 33% acetic acid before quantification by spectophotometry at 
A590nm in a UV-160 Shimadzu UV-Visible Recording Spectophotometer
®. 
The protocol described for the XTT assay was performed as described by Ramage et al.70. 
The colorimetric reduction of XTT by cellular enzymes measures biofilm metabolic 
activity. Formed biofilm was washed twice with PBS (Phosphate-Buffered Saline), 
followed by the addition of 1ml of XTT solution (25µl XTT (500mg/ml); 0,2µl 
Menadione 10 mM; 1ml PBS) to each well. Plates were then incubated for 3 hours in the 
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dark at 35ºC before spectophometric reading at A492nm in a UV-160 Shimadzu UV-Visible 
Recording Spectophotometer®. 
 
Yeast Flow Cytometric Microsphere Adhesion Assay 
The microsphere adhesion protocol assay was performed as described by Silva-Dias et 
al.39. After growing C. parapsilosis BC014 and NDT80/ndt80 strains on Sabouraud broth 
medium at 180 rpm at 30ºC overnight, 1ml of cell suspension was centrifuged for 4 min 
at 6000 g and ressuspended in 1ml of PBS. 
Yeast suspension concentration was adjusted to approximately 2x106 cells/ml in PBS; 
200 µl of this suspension was mixed with 200 µl of microspheres (aprox. 2x107 
spheres/ml) in a test tube and incubated for 30 min at 35ºC with agitation. Samples were 
read in a flow cytometer on the fluorescence channel FL3. Cytometric assays were 
performed in a FACSCalibur cytometer (BD Biosciences, Sydney, Australia) standard 
model equipped with 3 photomultiplayers (PMTs), standard filters, and a 15-mW 488-nm 
Argon laser and using CellQuest Pro software (version 4.0.2). Results correspond to 
triplicate experiments. 
 
 
Statistical analysis 
Results were analyzed using Student’s t test. p values <0.05 were considered statistical 
significant.  
 
 
IX.Results/ Discussion 
Disruption of C. parapsilosis NDT80 and UPC2 genes  
In order to knockout NDT80 and UPC2 genes in the C. parapsilosis BC014 clinical strain 
it was used the SAT1-flipper cassette system. This technique uses a non-auxotrophic 
dominant resistance marker, SAT1, which confers resistance to nourseotricin, a member 
of the streptothricin group of antibiotics produced by Streptomyces noursei49. SAT1 gene 
from the bacterial transposon Tn1825 encodes for a streptothricin acetyltransferase, 
which inactivates the antibiotic48. This cassete was first developed for C. albicans as 
described on Reuss et al.22. Some years later it was adapted to C. parapsilosis by Ding et 
al.14. SAT1-flipper cassete are constituted by the resistance gene referred above, 
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controlled by ACT1 gene promoter; FLP gene, encoding for a recombinase, regulated by 
MAL2 gene promoter, and flanked by two FRT (Flippase Recognition Target) (Fig. 1) 
 
 
 
 
 
 
Figure 1. SAT1-flipper cassete (pCD8) scheme comprising SAT1 gene (CaSAT1), nouseothricin resistance marker, and FLP gene 
(represented in the green boxes). Expression of these genes are controlled by C. parapsilosis ACT1 (ACT1p) and MAL2 (MAL2p) 
promoter regions (represented by the bent arrows), respectively. Transcription termination sequence of the C. albicans ACT1 gene 
(ACT1t) is downstream CaFLP gene (filled circle). 
 
After C. parapsilosis transformation, the resistance marker (CaSAT1) allows the selection 
of transformants that integrated the cassette into the genome, which enables their growth 
in the presence of nourseothricin. Since C. parapsilosis is a diploid yeast and in order to 
use the same selective marker to disrupt the second copy of the gene, FLP recombinase 
gene expression must be activated by growing transformants in maltose as a sole source 
of carbon. FLP activation induces cassette excision.  
Gene disruption occurs by homologous recombination, therefore disruption cassette is 
constructed by cloning target gene flanking sequences in the unique restriction sites on 
both sides of the SAT1 flipper cassette. These sites are located both upstream and 
downstream of the cassete. In this study, we amplified the C. parapsilosis NDT80 and the 
UPC2 upstream and downstream sequences which were cloned on both ends of the SAT1 
flipper cassette. 
Cloning of these sequences into pCD8 plasmid were confirmed by PCR after the 
transformation in E. coli DH5α. PCR positive clones were sequenced.  
 
 
C. parapsilosis transformation  
Since C. parapsilosis is a diploid organism, the construction of homozygous mutants 
requires recycling of the selective marker after disruption of the first allele of the target 
gene to allow its subsequent use in a second round of transformation for inactivation of 
the remaining wild-type allele21 (Fig. 2) 
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Figure 2. C. parapsilosis NDT80 gene disruption by homologous recombination of  the upstream and downstream sequences of the 
gene with its genomic target locus. Upstream and downstream regions were previously cloned in the SAT flipper cassette in thpnI/ApaI 
and SacII/SacI restriction sites respectively 
 
The disruption cassetes pNG3 and pNG4 (containing upstream and downstream 
sequences of the UPC2 and NDT80 genes, respectively) were amplified by PCR and then 
transformed into C. parapsilosis BC014 by electroporation. From the transformation with 
pNG4 cassete resulted 47 Nourseotricin-resistant colonies after incubation for 2-3 days 
at 30ºC. These colonies were screened by PCR as described above in order to confirm 
pNG4 integration at its correct loci, and subsequently the deletion of one copy of the gene. 
The amplification of a 2.8 kb fragment in the clone Cp23 confirmed the integration of 
pNG4 at its target location (Fig. 3). 
Transformation of BC014 with pNG3 cassette, used to disrupt the UPC2 gene, originated 
54 nourseotricin-resistant colonies. However, none of the clones obtained have integrated 
the cassette at UPC2 gene locus.   
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Figure 3 -  Amplification of a 2.8 kb fragment confirming the integration of the pNG4 cassete at its target gene NDT80, and therefore 
its one copy delection, originating Cp23 clone. M represents the 100 bp Nzytech® ladder III.  
 
 
pNG4 recycling 
The excision of the cassette on this clone was done by growing Cp23 strain in YPM 
medium. This growth condition will induce the activation of MAL2 promoter and 
consequently FLP recombinase activity. FLP recombinase will cleavage pNG4 cassete in 
FRT regions excising it from the genome. The excised clones were selected through their 
susceptibility to Nou 20 µg ml-1. Nourseotricin susceptible colonies are the ones expected 
to have removed sucessfully pNG4 (Fig. 4). 
 
 
 
 
 
 
 
 
 
Figure 4. Selection of recycled pNG4 clones in Nou 20 µg ml-1. Susceptible colonies to nouseothricin are chosen by its reduced size 
indicating growth inhibition. 
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After cassette recycling, six of the small transformants were plated onto YPD medium 
supplemented with Nou 200 µg ml-1 in order to reconfirm cassette excision. Three of the 
selected clones presented growth absence (Cp1, Cp2, Cp3) (Fig. 5) 
 
 
Figure 5. Confirmation of the pNG4 excision from C. parapsilosis BC014 genome. Clones were grown in YPD agar plate (A) and 
YPD agar plate supplemented with Nourseothricin 200µg ml-1 (B). Cp1, Cp2, Cp3 clones were susceptible to nourseothricin. 
 
Furthermore, pNG4 recycling in these clones was confirmed by PCR using primers 
located in the genome flanking region of the NDT80 gene and within the gene. As 
expected, two fragments were amplified in the PCR reaction. The band with 
approximately 3.0 kb represents the second allele with the intact gene, whilst the band 
with 1.1 kb correspond to the disrupted allele on the first transformation, containing only 
the upstream and downstream sequences of the NDT80 gene (Fig. 6). 
 
 
 
 
 
 
 
 
 
 
Figure 6. Confirmation of the disruption of one copy of the NDT80 gene (NDT80/ndt80). An intact copy of the gene was amplified 
(3.0 kb fragment) and a fragment of approximately 1.1 kb, which corresponds to the upstream and downstream regions of the disrupted 
copy. A positive control was made with a BC014 strain. M represents the 100 bp Nzytech® ladder III. 
 
Cp2 
 
Cp3 
 
Cp1 
 
+ 
 
- 
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Several transformations of the Cp23 clone (NDT80/ndt80) with the pNG4 cassete were 
carried out in order to obtain the homozygous deleted mutant. However, in thirty colonies 
obtained after transformation none of them was found to have pNG4 cassette in the 
NDT80 locus, after PCR assessment. The difficulty faced in the deletion of the second 
copy of the NDT80 gene as well as limitations of SAT1-flipper method is well 
documented on other studies14,60.  
The NDT80 gene deletion would be successful if pNG4 cassette recombined to the 
upstream and downstream sequences of the target gene in the second allele, which did not 
happened on our experimental work. The most probable explanation for this result is 
sistematic recombination of the cassette on the upstream and downstream sequences 
present in the disrupted allele, leaving the second allele intact. This possibility was 
already reported when using SAT1 flipper cassette to disrupt other genes60. 
One possible solution to this limitation of the SAT1-flipper method would be to construct 
other cassette possessing upstream and downstream sequences more distant from the 
target gene than the ones contained in pNG4. This approach would avoid the 
recombination with upstream and downstream sequences in the disrupted allele. 
 
Aneuploidy of NDT80 gene increased yeast adhesion 
Interestingly, C. parapsilosis Cp23 (NDT80/ndt80) grown in liquid media displayed a 
notorious increased adherence to abiotic surfaces, like glass, compared to the wild-type 
strain (BC014). Furthermore, Cp23 displayed a strong flocculation phenotype, indicating 
cell to cell adhesion (Fig. 7).  
 
 
 
 
 
 
 
 
Figure 7. C. parapsilosis Cp23 (NDT80/ndt80) displayed increased cell to cell adhesion flocculating when growing in YPD liquid 
media (B) comparatively to the wild-type strain BC014 (A). 
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In the scope of the results obtained, yeast adhesion ability to polystyrene microspheres 
was quantified by flow cytometry. Statistical differences between NDT80/ndt80 strain 
and wild-type were found in yeast adhesion profile. Interestingly, NDT80/ndt80 strain 
displayed 5 fold increased adhesion to polystyrene than wild-type (Fig. 8). 
 
  
Figure 8. NDT80 aneuploidy increases C. parapsilosis adhesion ability. Yeast adhesion ability to polystyrene beads was quantified 
using Flow Cytometric Microsphere Adhesion Assay. The NDT80/ndt80 strain displayed approximately five times more adhesion 
than the wild-type (BC014) strain. 
  
NDT80 aneuploidy triggers cell morphological changes 
Deletion of one copy of the NDT80 gene caused morphological cell phenotype shift. C. 
parapsilosis NDT80/ndt80 cells are bigger and elongated in comparison with the mainly 
yeast form displayed by BC014 wild-type cells (Fig.12) 
 
 
Figure 12 – C. parapsilosis morphological changes triggered by the deletion of one copy of NDT80 gene. (A) BC014 strain – cells 
display a predominant round and small morphologic type; (B) NDT80/ndt80 strain – cells present a bigger and elongated form. Cells 
were photographed after one day of growth on YPD agar plate at 35ºC. 
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In fact, NDT80 gene has been described in C. albicans as an essential gene for the 
completion of the cell separation process, as a direct transcriptional regulator of genes 
encoding among others, the chitinase Cht3p and the cell wall glucosidase Sun41p31. In C. 
albicans, it was shown that the delection of NDT80 gene caused cell separation defect.  
Our results suggest that NDT80 in C. parapsilosis may have a similar function as the one 
described for C. albicans. In fact, NDT80/ndt80 cells are elongated and form 
agglomerates which could indicate a cell separation defect. Other recent studies in 
budding yeast show that the deletion of one copy of NDT80 gene delays the meiotic 
commitment point. When compared to NDT80/NDT80, fewer NDT80/ndt80 cells commit 
to meiosis in prometaphase I , suggesting that the commitment point shifted to the end of 
prometaphase I/beginning of metaphase I, describing that this gene can be involved in the 
whole meiotic committment process62. 
 
 
SADH gene amplification 
To exclude any possibility of contamination during experimental work, the amplification 
of SADH gene was carried out. Exclusive to C. parapsilosis species, SADH restriction 
profile provide a simple, rapid and accurate method of identification of the species 
belonging to this complex52. The 716 bp fragment of the gene SADH was amplified, 
confirming that it was a C. parapsilosis complex strain (Fig.13-A). The following 
restriction using the BanI endonuclease provides the identification within the complex, 
being the C. parapsilosis sensu stricto the far most common of the three subspecies. 
After PCR product restriction with the BanI enzyme, it was clear that the strain with the 
deleted allele was a C. parapsilosis sensu stricto (NDT80/ndt80), once it displayed two 
bands, one of them corresponding to the restriction site of BanI (196 bp), as described for 
this species66  (Fig.13-B).  
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Aneuploidy of NDT80 gene increased biofilm formation 
Microbial adhesion is considered the first step given by an organism to form a microbial 
community embebbed in an extracellular matrix named as biofilm. Thus, microorganisms 
that are able to adhere to abiotic surfaces as well as to each other, are particularly prone 
to form biofilm. Among other characteristics, biofilms constitute a reservoir for 
antifungal resistance development since it functions as a protection against antifungal 
drugs. Since Cp23 displayed increased adhesion, cell-cell and to abiotic surfaces, we 
assessed its ability to form biofilm.   
Biofilm quantification was undertaken using two methodologies: Crystal Violet (CV) 
method, to assess the biomass, and the XTT reduction assay, to assess the metabolic 
activity.The CV method relies on the principle of staining the negative charged bacteria 
or polysaccharides67, but not distinguish living and dead cells, whereas the XTT method 
uses a redox indicator to enumerate spectrophotometrically viable cells in biofilm. So, 
this methods complement each other in a certain way to evaluate the biofilm formation 
potential. 
Only after one day of growth, it was visible to the naked eye differences between the 
Cp23 and wild-type strains. Only with 24 hours of incubation, NDT80/ndt80 strain has 
formed a substantial amount of biofilm compared to the wild-type strain (Fig. 9) 
Figure 13. Cp23 (NDT80/ndt80) strain belongs to C. parapsilosis sensu stricto (A) PCR amplification of the 716 bp fragment 
of the SADH gene using as template Cp23 genomic DNA. (B) Restriction of the SADH gene with BanI resctriction enzyme: the 
band with approximately 196 bp represents the restriction site of BanI identifying C. parapsilosis sensu stricto. M represents 
the 100 bp Nzytech® ladder III. 
 38 
 
 
 
Figure 9 – Differences in biofilm formation between NDT80/ndt80 and the wild-type strain after 24h of incubation at 35ºC on RPMI-
1640 medium in a 12-well microplate.  
  
 
For all the time frames (24 h, 48 h, 72 h), CV results shown that biofilms formed by Cp23 
contained significantly (2 fold) more biomass than BC014 (Fig. 10). However, no 
differences were found when assessing metabolic activity, using the XTT method, 
between biofilms formed by the wild-type and Cp23, at 24 h and 48 h (Fig. 11).     
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 10. Cp23 strain formed biofilms with increased amount of biomass than BC014. Biofilm formation was measuread using the CV 
method. Differences in biofilm formation found between Cp23 and wild-type were statistical significant at 24 h, 48 h and 72 h. 
 
 
(-) 
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Fig. 11- Biofilm metabolic activity displayed by Cp23(NDT80/ndt80) and BC014. Biofilm metabolic was measuread using the XTT 
method. There were no significant differences found between NDT80/ndt80 and the wild-type BC014 strain at 24 h and 48 h. 
 
 
Interestingly and against what we have found in C. parapsilosis, delection of NDT80 gene 
in C. albicans reveled to be detrimental for biofilm formation63. Moreover, it was shown 
that NDT80 function on S. cerevisae and C. albicans is clearly distinguishable on both 
species, in the former, it regulates meiosis64 and in the later, biofilm formation65.  
 
 
NDT80 and its role on C. parapsilosis 
 
The efficiency of microbial adhesion has an huge impact at various levels, namely 
ecological, industrial, and clinical, with either positive or negative repercussions40. 
Pathogenic bacteria and fungal cells can adhere to host tissues or to biomaterial used in 
common medical indwelling devices leading to biofilm formation, which frequently 
results in bloodstream infections associated to high mortality rates40,42. 
It is known that CaNdt80p is required for the modulation of different biological processes, 
such as cell separation, hyphal growth, virulence, and azole sensitivity. 
The findings on this experimental work are somewhat adjusted to the studies known to 
date on C.albicans. The delection of one allele of the TF CpNDT80 is proven to have an 
role on important cell functions, namely on cell wall  functions. The deletion of one 
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NDT80 allele has affected the biofilm formation and adherence potential of C. 
parapsilosis, being significantly different from the wild-type strain.  
Results obtained indicate that NDT80 gene is prone to be involved in adhesion, cell 
separation, hyphal growth, and virulence  mechanisms on C. parapsilosis, as it was 
described on C.albicans33.  
The literature describes that C. parapsilosis and C. albicans may have the same capacity 
of adherence although with some variations43, which suggest the same adherence 
mechanisms on both species. According to the studies done on C.albicans, Ndt80p is 
thought to act as a critical downstream effector promoting hypha formation and cell 
separation in response to different signals conveyed by different upstream pathways31, 
being therefore described as a multifunctional general regulator48. During the iniciation 
of the hyphal formation process, increased levels of cAMP activate Tpk2, one of the 
protein kinase isoforms, will phosphorylate Efg1, an exclusive nucleus protein that 
interveins on the hyphal growth. Ndt80 regulates the expression of this protein68,69. 
Moreover, in another study, gene expression microarray data comparing wild-type 
biofilms to deletion mutants of each regulator (one of them being Ndt80), it was proven 
that Ndt80 on C. albicans bound about to approximately 273 of 999 genes (27%) of 
promoters involved in biofilm formation, and it is correlated with the other biofilm 
regulators such as BCR1 and BRG1, forming an interconnected network of transcriptional 
regulators of biofilm development68,69. 
The deletion of the other NDT80 allele will be necessary to further conclude the role of 
this TF on C. parapsilosis. After, a functional comparison could be made between NDT80 
role in C. parapsilosis and C.albicans. 
Nevertheless, the knowledge of the genes involved on C. parapsilosis adhesion and 
biofilm formation is scarce. 
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X. Conclusion/Future perspectives 
Throughout this experimental work, the main objective was partially achieved. It 
occurred a phenotypic change on the susceptible clinical strain BC014,  when one allele 
of the NDT80 gene was disrupted. This phenotypic change may compromise the whole 
morphology of the cell , which suggest an important role of this transcription factor not 
only on the azole-resistance mechanism but also on the biofilm formation capacity of C. 
parapsilosis. The deletion of the second allele of NDT80 gene is of major importance in 
order to conclude definitely what is the role of the gene on the azole-resistance on this 
organism. 
Once the knowledge of the molecular mechanisms underlying antifungal resistance in C. 
parapsilosis are scarce comparatively to what is already known for C. albicans, it is 
critical to understand the role of the TF such as UPC2 and NDT80 to further establish a 
parallel with other species of Candida spp.  
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